Surmodics, Inc. (SRDX)
NASDAQ: SRDX · Real-Time Price · USD
37.51
-0.29 (-0.77%)
Oct 29, 2024, 4:00 PM EDT - Market closed
Surmodics Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | Sep '19 Sep 30, 2019 | 2018 - 2014 |
Revenue | 120.82 | 132.58 | 99.95 | 105.14 | 94.86 | 100.08 | Upgrade
|
Revenue Growth (YoY) | -7.49% | 32.65% | -4.93% | 10.83% | -5.21% | 23.04% | Upgrade
|
Cost of Revenue | 23.15 | 24.97 | 20.34 | 17.68 | 65.51 | 66.27 | Upgrade
|
Gross Profit | 97.67 | 107.62 | 79.61 | 87.46 | 29.36 | 33.81 | Upgrade
|
Selling, General & Admin | 55.06 | 51.88 | 46.94 | 31.58 | 28.39 | 24.55 | Upgrade
|
Research & Development | 46.6 | 46.6 | 50.61 | 48.93 | - | - | Upgrade
|
Operating Expenses | 105.15 | 102.02 | 101.69 | 83.3 | 30.61 | 26.96 | Upgrade
|
Operating Income | -7.48 | 5.6 | -22.09 | 4.16 | -1.25 | 6.86 | Upgrade
|
Interest Expense | -3.55 | -3.49 | -0.6 | -0.31 | -0.13 | -0.15 | Upgrade
|
Interest & Investment Income | 2.03 | 1.08 | 0.1 | 0.12 | 0.66 | 1.1 | Upgrade
|
Currency Exchange Gain (Loss) | -0.16 | -0.25 | 0.1 | -0.17 | -0.25 | 0.13 | Upgrade
|
Other Non Operating Income (Expenses) | - | - | - | - | 0 | 0 | Upgrade
|
EBT Excluding Unusual Items | -9.16 | 2.94 | -22.48 | 3.8 | -0.98 | 7.94 | Upgrade
|
Merger & Restructuring Charges | - | -1.28 | - | -1.05 | - | - | Upgrade
|
Gain (Loss) on Sale of Investments | - | - | - | - | -0.48 | 0.01 | Upgrade
|
Asset Writedown | - | - | - | - | - | -0.26 | Upgrade
|
Legal Settlements | - | - | - | - | - | 0.6 | Upgrade
|
Other Unusual Items | - | 0.83 | -0.01 | 3.6 | - | 0.16 | Upgrade
|
Pretax Income | -9.16 | 2.49 | -22.49 | 6.35 | -1.45 | 7.56 | Upgrade
|
Income Tax Expense | -7.76 | 4.02 | 4.78 | 2.11 | -2.58 | -0.03 | Upgrade
|
Earnings From Continuing Operations | -1.4 | -1.54 | -27.27 | 4.24 | 1.12 | 7.59 | Upgrade
|
Net Income | -1.4 | -1.54 | -27.27 | 4.24 | 1.12 | 7.59 | Upgrade
|
Net Income to Common | -1.4 | -1.54 | -27.27 | 4.24 | 1.12 | 7.59 | Upgrade
|
Net Income Growth | - | - | - | 277.29% | -85.21% | - | Upgrade
|
Shares Outstanding (Basic) | 14 | 14 | 14 | 14 | 14 | 13 | Upgrade
|
Shares Outstanding (Diluted) | 14 | 14 | 14 | 14 | 14 | 14 | Upgrade
|
Shares Change (YoY) | 0.86% | 0.83% | -0.52% | 1.28% | 0.24% | 4.73% | Upgrade
|
EPS (Basic) | -0.10 | -0.11 | -1.96 | 0.31 | 0.08 | 0.57 | Upgrade
|
EPS (Diluted) | -0.10 | -0.11 | -1.96 | 0.30 | 0.08 | 0.55 | Upgrade
|
EPS Growth | - | - | - | 275.00% | -85.45% | - | Upgrade
|
Free Cash Flow | -5.86 | 7.6 | -20.59 | 10.11 | 10.34 | 2.04 | Upgrade
|
Free Cash Flow Per Share | -0.41 | 0.54 | -1.48 | 0.72 | 0.75 | 0.15 | Upgrade
|
Gross Margin | 80.84% | 81.17% | 79.65% | 83.19% | 30.95% | 33.79% | Upgrade
|
Operating Margin | -6.19% | 4.23% | -22.10% | 3.95% | -1.32% | 6.85% | Upgrade
|
Profit Margin | -1.16% | -1.16% | -27.29% | 4.03% | 1.18% | 7.59% | Upgrade
|
Free Cash Flow Margin | -4.85% | 5.73% | -20.60% | 9.62% | 10.90% | 2.04% | Upgrade
|
EBITDA | 1.23 | 14.13 | -12.94 | 12.17 | 6.01 | 14.17 | Upgrade
|
EBITDA Margin | 1.02% | 10.65% | -12.95% | 11.58% | 6.34% | 14.16% | Upgrade
|
D&A For EBITDA | 8.71 | 8.52 | 9.14 | 8.02 | 7.26 | 7.31 | Upgrade
|
EBIT | -7.48 | 5.6 | -22.09 | 4.16 | -1.25 | 6.86 | Upgrade
|
EBIT Margin | -6.19% | 4.23% | -22.10% | 3.95% | -1.32% | 6.85% | Upgrade
|
Effective Tax Rate | - | 161.76% | - | 33.23% | - | - | Upgrade
|
Revenue as Reported | 120.82 | 132.58 | 99.95 | 105.14 | 94.86 | 100.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.